Saturday, November 23, 2024
HomeTagsPromontory Therapeutics

Promontory Therapeutics

Promontory Therapeutics Completes Enrollment of Phase 2 Trial of PT-112 in Late-Line Patients with Metastatic Castration-Resistant Prostate Cancer

Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing immunogenic small molecule approaches in oncology, has completed enrollment of its Phase 2 clinical trial...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics